Thuy V Tran
Examiner (ID: 6857, Phone: (571)272-1828 , Office: P/2844 )
Most Active Art Unit | 2821 |
Art Unit(s) | 2821, 2844, 2856, 2814 |
Total Applications | 2202 |
Issued Applications | 1909 |
Pending Applications | 47 |
Abandoned Applications | 246 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18284930
[patent_doc_number] => 20230100402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => INDUCTION OF SYNTHETIC LETHALITY WITH EPIGENETIC THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/946416
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946416 | INDUCTION OF SYNTHETIC LETHALITY WITH EPIGENETIC THERAPY | Sep 15, 2022 | Pending |
Array
(
[id] => 18404532
[patent_doc_number] => 20230165883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING CORONARY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/893777
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17893777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/893777 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING CORONARY DISORDERS | Aug 22, 2022 | Pending |
Array
(
[id] => 18376269
[patent_doc_number] => 20230151352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => METHOD FOR PRODUCING AND PURIFYING RNA, COMPRISING AT LEAST ONE STEP OF TANGENTIAL FLOW FILTRATION
[patent_app_type] => utility
[patent_app_number] => 17/820242
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820242 | Method for producing and purifying RNA, comprising at least one step of tangential flow filtration | Aug 15, 2022 | Issued |
Array
(
[id] => 18391240
[patent_doc_number] => 20230159458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/817267
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817267 | SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES | Aug 2, 2022 | Pending |
Array
(
[id] => 18019181
[patent_doc_number] => 20220370680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => CHITOSAN-CONTAINING FORMULATIONS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/817241
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817241 | CHITOSAN-CONTAINING FORMULATIONS AND METHODS OF MAKING AND USING THE SAME | Aug 2, 2022 | Pending |
Array
(
[id] => 18496111
[patent_doc_number] => 20230218655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => CANCER TREATMENTS
[patent_app_type] => utility
[patent_app_number] => 17/878747
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17878747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/878747 | CANCER TREATMENTS | Jul 31, 2022 | Pending |
Array
(
[id] => 17988777
[patent_doc_number] => 20220354814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => COMPOSITIONS COMPRISING CITRULLINE AND LEUCINE AND THEIR USE IN THE TREATMENT OF DIABETES AND METABOLIC SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/871515
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/871515 | Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome | Jul 21, 2022 | Issued |
Array
(
[id] => 18036449
[patent_doc_number] => 20220380664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => SEMICONDUCTING LIGHT EMITTING MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/869352
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869352
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/869352 | SEMICONDUCTING LIGHT EMITTING MATERIAL | Jul 19, 2022 | Pending |
Array
(
[id] => 18253679
[patent_doc_number] => 20230080718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => SILICON PRECURSOR MATERIALS, SILICON-CONTAINING FILMS, AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/859953
[patent_app_country] => US
[patent_app_date] => 2022-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17859953
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/859953 | SILICON PRECURSOR MATERIALS, SILICON-CONTAINING FILMS, AND RELATED METHODS | Jul 6, 2022 | Pending |
Array
(
[id] => 18211582
[patent_doc_number] => 20230057845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => PREPARATION METHOD OF FUNCTIONAL SILANES
[patent_app_type] => utility
[patent_app_number] => 17/809239
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17809239
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/809239 | Preparation method of functional silanes | Jun 26, 2022 | Issued |
Array
(
[id] => 18634939
[patent_doc_number] => 11759510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
[patent_app_type] => utility
[patent_app_number] => 17/848466
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 15242
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848466
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848466 | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates | Jun 23, 2022 | Issued |
Array
(
[id] => 19120062
[patent_doc_number] => 11964023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
[patent_app_type] => utility
[patent_app_number] => 17/848462
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14257
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848462 | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates | Jun 23, 2022 | Issued |
Array
(
[id] => 18634952
[patent_doc_number] => 11759523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
[patent_app_type] => utility
[patent_app_number] => 17/848456
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14262
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848456
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848456 | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates | Jun 23, 2022 | Issued |
Array
(
[id] => 18634940
[patent_doc_number] => 11759511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
[patent_app_type] => utility
[patent_app_number] => 17/848468
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 15245
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848468 | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates | Jun 23, 2022 | Issued |
Array
(
[id] => 17895378
[patent_doc_number] => 20220305040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => NICOTINAMIDE RIBOSIDE FOR USE IN TREATING OR PREVENTING LIVER DAMAGE
[patent_app_type] => utility
[patent_app_number] => 17/842042
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842042
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842042 | NICOTINAMIDE RIBOSIDE FOR USE IN TREATING OR PREVENTING LIVER DAMAGE | Jun 15, 2022 | Pending |
Array
(
[id] => 17897013
[patent_doc_number] => 20220306675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => 2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/833780
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833780 | 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds | Jun 5, 2022 | Issued |
Array
(
[id] => 18077271
[patent_doc_number] => 20220402883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/805634
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17805634
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/805634 | COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION | Jun 5, 2022 | Pending |
Array
(
[id] => 19290411
[patent_doc_number] => 12029750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Folic compositions and methods for treatment of diabetic neuropathies
[patent_app_type] => utility
[patent_app_number] => 17/805479
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5652
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17805479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/805479 | Folic compositions and methods for treatment of diabetic neuropathies | Jun 5, 2022 | Issued |
Array
(
[id] => 17953391
[patent_doc_number] => 11479482
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-10-25
[patent_title] => Hydrogen-bonded organic framework (HOF) for water uptake
[patent_app_type] => utility
[patent_app_number] => 17/828591
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 20
[patent_no_of_words] => 7102
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17828591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/828591 | Hydrogen-bonded organic framework (HOF) for water uptake | May 30, 2022 | Issued |
Array
(
[id] => 18004853
[patent_doc_number] => 20220363619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES
[patent_app_type] => utility
[patent_app_number] => 17/749293
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17749293
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/749293 | Pharmaceutical compositions comprising monoterpenes | May 19, 2022 | Issued |